| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate |
2001-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_502691e2ea98fc068b257e3c3a683a54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ed4c59d97d409132878b74952b5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23cc4bbb348c366d23bcaaa35cd938d4 |
| publicationDate |
2003-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003153620-A1 |
| titleOfInvention |
Treating eczema and/or psoriasis |
| abstract |
The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404745-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006219576-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012265119-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005118070-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007225368-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011065627-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299120-B2 |
| priorityDate |
2000-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |